US Patent Issued to James Summerton on Sept. 1 for "Compositions and methods for suppressing intracellular synthesis of the beta subunit of human chorionic gonadotropin" (Oregon Inventors)

Posted On: 2026-09-01

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,896, issued on Sept. 1, was assigned to James Summerton (Corvallis, Ore.). "Compositions and methods for suppressing intracellular synthesi... Read More

US Patent Issued to BEIJING QL BIOPHARMACEUTICAL on Sept. 1 for "Pharmaceutical compositions of polypeptide conjugates and methods of uses thereof" (Chinese Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,897, issued on Sept. 1, was assigned to BEIJING QL BIOPHARMACEUTICAL Co. LTD. (Beijing). "Pharmaceutical compositions of polypeptide conjug... Read More

US Patent Issued to Purdue Research Foundation on Sept. 1 for "Fibroblast activation protein (FAP)-targeted antifibrotic therapy" (Indiana Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,898, issued on Sept. 1, was assigned to Purdue Research Foundation (West Lafayette, Ind.). "Fibroblast activation protein (FAP)-targeted an... Read More

US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS, SHANGHAI HENGRUI PHARMACEUTICAL on Sept. 1 for "Pharmaceutical compositions comprising an anti-claudin 18.2 antibody-drug conjugate and method of use thereof to treat a tumor or cancer" (Chinese Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,899, issued on Sept. 1, was assigned to JIANGSU HENGRUI PHARMACEUTICALS Co. LTD. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co... Read More

US Patent Issued to University of Washington on Sept. 1 for "Non-viral immuno-targeting" (Washington Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,900, issued on Sept. 1, was assigned to University of Washington (Seattle). "Non-viral immuno-targeting" was invented by Nicholas P. Whiteh... Read More

US Patent Issued to Mythic Therapeutics on Sept. 1 for "Antigen-binding protein constructs and uses thereof" (Massachusetts Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,901, issued on Sept. 1, was assigned to Mythic Therapeutics Inc.. "Antigen-binding protein constructs and uses thereof" was invented by Ale... Read More

US Patent Issued to Cavalry Biosciences, University of Florida Research Foundation on Sept. 1 for "Compositions for targeting muscle cells and uses thereof" (California, Florida, Vermont, Oregon Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,902, issued on Sept. 1, was assigned to Cavalry Biosciences Inc. and University of Florida Research Foundation Inc. (Gainsville, Fla.). "Co... Read More

US Patent Issued to THE UNIVERSITY OF TOKYO, COMPLECURE on Sept. 1 for "Conjugate of phthalocy anine dye and antibody or peptide" (Japanese Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,903, issued on Sept. 1, was assigned to THE UNIVERSITY OF TOKYO (Tokyo) and COMPLECURE INC. (Tokyo). "Conjugate of phthalocy anine dye and ... Read More

US Patent Issued to President and Fellows of Harvard College on Sept. 1 for "Stabilized trioxacarcin antibody drug conjugates and uses thereof" (Massachusetts Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,904, issued on Sept. 1, was assigned to President and Fellows of Harvard College (Cambridge, Mass.). "Stabilized trioxacarcin antibody drug... Read More

US Patent Issued to AstraZeneca UK, Daiichi Sankyo on Sept. 1 for "Combination of anti-HER2 antibody-drug conjugate and PARP1 selective inhibitor" (British, American Inventors)

Posted On: 2026-09-01

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,905, issued on Sept. 1, was assigned to AstraZeneca UK Ltd. (Cambridge, Great Britain) and Daiichi Sankyo Co. Ltd. (Tokyo). "Combination of... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to James Summerton on Sept. 1 for "Compositions and methods for suppressing intracellular synthesis of the beta subunit of human chorionic gonadotropin" (Oregon Inventors)

US Patent Issued to BEIJING QL BIOPHARMACEUTICAL on Sept. 1 for "Pharmaceutical compositions of polypeptide conjugates and methods of uses thereof" (Chinese Inventors)

US Patent Issued to Purdue Research Foundation on Sept. 1 for "Fibroblast activation protein (FAP)-targeted antifibrotic therapy" (Indiana Inventors)

US Patent Issued to JIANGSU HENGRUI PHARMACEUTICALS, SHANGHAI HENGRUI PHARMACEUTICAL on Sept. 1 for "Pharmaceutical compositions comprising an anti-claudin 18.2 antibody-drug conjugate and method of use thereof to treat a tumor or cancer" (Chinese Inventors)

US Patent Issued to University of Washington on Sept. 1 for "Non-viral immuno-targeting" (Washington Inventors)

US Patent Issued to Mythic Therapeutics on Sept. 1 for "Antigen-binding protein constructs and uses thereof" (Massachusetts Inventors)

US Patent Issued to Cavalry Biosciences, University of Florida Research Foundation on Sept. 1 for "Compositions for targeting muscle cells and uses thereof" (California, Florida, Vermont, Oregon Inventors)

US Patent Issued to THE UNIVERSITY OF TOKYO, COMPLECURE on Sept. 1 for "Conjugate of phthalocy anine dye and antibody or peptide" (Japanese Inventors)

US Patent Issued to President and Fellows of Harvard College on Sept. 1 for "Stabilized trioxacarcin antibody drug conjugates and uses thereof" (Massachusetts Inventors)

US Patent Issued to AstraZeneca UK, Daiichi Sankyo on Sept. 1 for "Combination of anti-HER2 antibody-drug conjugate and PARP1 selective inhibitor" (British, American Inventors)